Publications

Salmonella Combination Vaccines: Moving Beyond Typhoid

MacLennan CA. et al, (2023), Open Forum Infectious Diseases, 10, S58 - S66

Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections

Abuga KM. et al, (2023), Wellcome Open Research, 8, 48 - 48

Consequences of Shigella infection in young children: a systematic review.

Libby TE. et al, (2023), Int J Infect Dis

Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum.

Elias SC. et al, (2023), Heliyon, 9

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Jossi SE. et al, (2023), Frontiers in Immunology, 14

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.

Cohen D. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Impact and Control of Sugar Size in Glycoconjugate Vaccines.

Stefanetti G. et al, (2022), Molecules (Basel, Switzerland), 27

Frontiers in Shigella Vaccine Development.

MacLennan CA. and Steele AD., (2022), Vaccines, 10

The Shigella Vaccines Pipeline.

MacLennan CA. et al, (2022), Vaccines, 10

Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo.

Van Puyvelde S. et al, (2022), mBio

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.

Pavlinac PB. et al, (2022), Vaccines, 10

The Background, Role and Approach for Development of a Controlled Human Infection Model for Nontyphoidal Salmonella.

MacLennan CA., (2021), Current topics in microbiology and immunology

An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella.

Siggins MK. and MacLennan CA., (2021), Vaccine

Typhoid in India: An Age-old Problem With an Existing Solution.

Kumar S. et al, (2021), The Journal of infectious diseases, 224, S469 - S474

Critical needs in advancing Shigella vaccines for global health

MacLennan CA. et al, (2021), The Journal of Infectious Diseases

The immunology of infection

Gilchrist JJ. and MacLennan CA., (2021), Medicine (United Kingdom)

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface

Domínguez-Medina CC. et al, (2020), Nature Communications, 11

Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.

Micoli F. et al, (2020), Proceedings of the National Academy of Sciences of the United States of America, 117, 24443 - 24449

Outer membrane vesicle vaccines

Micoli F. and MacLennan CA., (2020), Seminars in Immunology, 50, 101433 - 101433

Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?

Steele AD. et al, (2020), Clinical Infectious Diseases, 71, S185 - S190

Cookies on this website

Publications